IP Library Granted Patent US 6,689,765
Granted Patent Utility
US 6,689,765 · App. 10/061,011

Piperazine derivatives useful as CCR5 antagonists

Inventors: Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick, Michael Miller, Bernard R. Neustadt, Anandan Palani, Elizabeth M. Smith, Ruo Steensma, Jayaram R. Tagat, Susan F. Vice, Mark Laughlin, Eric J. Gilbert, Marc A. Labroli
Patented Case View Patent ↗
Granted: Feb 10, 2004 Filed: Jan 30, 2002
Inventors
Bahige M. Baroudy
John W. Clader
Hubert Josien
Stuart W. McCombie
Brian McKittrick
Michael Miller
Bernard R. Neustadt
Anandan Palani
Elizabeth M. Smith
Ruo Steensma
Jayaram R. Tagat
Susan F. Vice
Mark Laughlin
Eric J. Gilbert
Marc A. Labroli
Assignee (at issue)
SCHERING CORPORATION

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,689,765
App. No.
10/061,011
Filed
2002-01-30
Granted
2004-02-10
Kind
B2